{
  "disease_name": "Primary hyperoxaluria",
  "orpha_code": "416",
  "drugs": [
    {
      "name": "Stiripentol",
      "substance_url": "/en/drug/substance/41778?name=416&mode=orpha&region=&status=all",
      "substance_id": "41778",
      "regulatory_url": "/en/drug/regulatory/589315?name=416&mode=orpha&region=",
      "regulatory_id": "589315",
      "is_tradename": false,
      "is_medical_product": true,
      "is_available_in_us": true,
      "is_available_in_eu": true,
      "is_specific": true
    },
    {
      "name": "Nedosiran",
      "substance_url": "/en/drug/substance/524602?name=416&mode=orpha&region=&status=all",
      "substance_id": "524602",
      "regulatory_url": "/en/drug/regulatory/528536?name=416&mode=orpha&region=",
      "regulatory_id": "528536",
      "is_tradename": false,
      "is_medical_product": true,
      "is_available_in_us": false,
      "is_available_in_eu": true,
      "is_specific": true
    },
    {
      "name": "Bacillus subtilis oxalate decarboxylase",
      "substance_url": "/en/drug/substance/493796?name=416&mode=orpha&region=&status=all",
      "substance_id": "493796",
      "regulatory_url": "/en/drug/regulatory/494616?name=416&mode=orpha&region=",
      "regulatory_id": "494616",
      "is_tradename": false,
      "is_medical_product": true,
      "is_available_in_us": false,
      "is_available_in_eu": true,
      "is_specific": true
    },
    {
      "name": "Synthetic double-stranded siRNA oligonucleotide directed against hydroxyacid oxidase 1 mRNA and covalently linked to a ligand containing three N-acetylgalactosamine residues",
      "substance_url": "/en/drug/substance/458734?name=416&mode=orpha&region=&status=all",
      "substance_id": "458734",
      "regulatory_url": "/en/drug/regulatory/458735?name=416&mode=orpha&region=",
      "regulatory_id": "458735",
      "is_tradename": false,
      "is_medical_product": true,
      "is_available_in_us": false,
      "is_available_in_eu": true,
      "is_specific": true
    },
    {
      "name": "5-((4'-(3,3-difluorocyclobutyl)-[1,1'-biphenyl]-4-yl)oxy)-1H-1,2,3-triazole-4-carboxylic acid",
      "substance_url": "/en/drug/substance/628274?name=416&mode=orpha&region=&status=all",
      "substance_id": "628274",
      "regulatory_url": "/en/drug/regulatory/628275?name=416&mode=orpha&region=",
      "regulatory_id": "628275",
      "is_tradename": false,
      "is_medical_product": true,
      "is_available_in_us": false,
      "is_available_in_eu": true,
      "is_specific": true
    },
    {
      "name": "Lipid nanoparticle encapsulating a messenger RNA for the CRISPR-based gene editor Cas12i2v2.1, and an HAO1- specific guide RNA",
      "substance_url": "/en/drug/substance/695311?name=416&mode=orpha&region=&status=all",
      "substance_id": "695311",
      "regulatory_url": "/en/drug/regulatory/695440?name=416&mode=orpha&region=",
      "regulatory_id": "695440",
      "is_tradename": false,
      "is_medical_product": true,
      "is_available_in_us": true,
      "is_available_in_eu": false,
      "is_specific": true
    },
    {
      "name": "Lipid nanoparticles containing CRISPR/Cas12HF mRNA and a CRISPR RNA (crRNA) targeting the HAO1 gene",
      "substance_url": "/en/drug/substance/688334?name=416&mode=orpha&region=&status=all",
      "substance_id": "688334",
      "regulatory_url": "/en/drug/regulatory/688472?name=416&mode=orpha&region=",
      "regulatory_id": "688472",
      "is_tradename": false,
      "is_medical_product": true,
      "is_available_in_us": true,
      "is_available_in_eu": false,
      "is_specific": true
    },
    {
      "name": "2-(2-(cyclopropylmethyl)-1-(3-fluoro-4-sulfamoylbenzyl)-5-(4-fluorophenyl)-1H-pyrrol-3-yl)-6-methylpyrimidine-4-carboxylic acid",
      "substance_url": "/en/drug/substance/687138?name=416&mode=orpha&region=&status=all",
      "substance_id": "687138",
      "regulatory_url": "/en/drug/regulatory/687314?name=416&mode=orpha&region=",
      "regulatory_id": "687314",
      "is_tradename": false,
      "is_medical_product": true,
      "is_available_in_us": true,
      "is_available_in_eu": false,
      "is_specific": true
    },
    {
      "name": "Burixafor",
      "substance_url": "/en/drug/substance/689505?name=416&mode=orpha&region=&status=all",
      "substance_id": "689505",
      "regulatory_url": "/en/drug/regulatory/689915?name=416&mode=orpha&region=",
      "regulatory_id": "689915",
      "is_tradename": false,
      "is_medical_product": true,
      "is_available_in_us": true,
      "is_available_in_eu": false,
      "is_specific": false
    },
    {
      "name": "Treosulfan",
      "substance_url": "/en/drug/substance/90799?name=416&mode=orpha&region=&status=all",
      "substance_id": "90799",
      "regulatory_url": "/en/drug/regulatory/136690?name=416&mode=orpha&region=",
      "regulatory_id": "136690",
      "is_tradename": false,
      "is_medical_product": true,
      "is_available_in_us": true,
      "is_available_in_eu": false,
      "is_specific": false
    },
    {
      "name": "busulfan",
      "substance_url": "/en/drug/substance/46335?name=416&mode=orpha&region=&status=all",
      "substance_id": "46335",
      "regulatory_url": "/en/drug/regulatory/131973?name=416&mode=orpha&region=",
      "regulatory_id": "131973",
      "is_tradename": false,
      "is_medical_product": true,
      "is_available_in_us": true,
      "is_available_in_eu": false,
      "is_specific": false
    }
  ],
  "processing_timestamp": "2025-07-17T19:20:09.400508",
  "run_number": 1,
  "total_drugs_found": 11,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=Primary+hyperoxaluria&orphaCode=416&name=416&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "Primary hyperoxaluria",
    "orphaCode": "416",
    "name": "416",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}